Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
ID: 356387Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356387

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-24-255.html
Timeline
    Description

    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering administrative supplements aimed at enhancing diversity within the research and entrepreneurial workforce supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. This funding opportunity is designed to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, facilitating their involvement in ongoing research projects without leading independent clinical trials. The initiative emphasizes the importance of diverse perspectives in advancing health-related research and professional development, with eligible applicants including small businesses and various research candidates. Interested parties should note that the application deadline is October 13, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-255.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-24-255.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), announces funding opportunities for administrative supplements targeting enhanced diversity within research and entrepreneurial workforces supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. The purpose is to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, aiming to advance research training and professional development. This funding initiative allows applications to support candidates without leading independent clinical trials and encourages participation in research led by mentors. The program seeks to improve the overall impact of ongoing projects by incorporating various individuals' perspectives and experiences into the application process. Eligible participants include undergraduate students, degree holders, graduate students, postdoctoral scholars, and independent researchers, with specific guidance on budgetary constraints and submission protocols. Applicants must comply with NIH and CDC policies, ensuring inclusivity and adherence to project scopes. The program will evaluate applications based on the proposed experience's integration into existing research, the candidate's qualifications, and the demonstration of adequate mentorship.
    Similar Opportunities
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Small Business Technology Transfer (STTR) program, aimed at developing technologies to improve minority health and eliminate health disparities. Eligible applicants, specifically United States small business concerns (SBCs), are invited to submit grant applications for the R41/R42 program, which may include clinical trials, focusing on innovative solutions that are effective, affordable, and culturally acceptable for underserved populations. This initiative emphasizes the importance of addressing health inequities through technology, including disease self-management tools and mobile health solutions, with applications due by December 9, 2026. For further details, applicants can refer to the full announcement at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity" (PAR-22-181), aimed at enhancing the diversity of the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program emphasizes the importance of addressing health disparities and promoting diverse representation in science, with funding allocations of up to $10 million for NINDS and $5 million for NIDA/NIMH, among others, for a maximum project period of five years. Interested applicants should submit their proposals by June 6, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIAID and NIDDK Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity," aimed at enhancing diversity within the biomedical and public health research sectors. This grant supports research projects from New Investigators—those who have not previously secured substantial independent NIH funding—and At-Risk Investigators, who face potential funding loss, particularly from underrepresented backgrounds in health-related sciences. The initiative emphasizes the importance of diverse perspectives in addressing health disparities and requires applicants to demonstrate a commitment to diversity, equity, inclusion, and accessibility in their proposals. Applications are open until September 7, 2025, with no budget limits specified, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-275.html.
    Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), has announced the Innovation Corps (I-Corps) at NIH Program, aimed at enhancing the commercialization of biomedical innovations from Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I projects. This program provides administrative supplement awards to eligible small business concerns, facilitating entrepreneurship training and assisting teams in refining their commercialization strategies through customer discovery activities over an eight-week course. With a total funding pool of up to $2.64 million available for up to 48 awards, individual grants are capped at $55,000, and applications must be submitted by January 31, 2025. Interested applicants are encouraged to contact NIH Grants Information at grantsinfo@nih.gov for further guidance before applying.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)" aimed at fostering a diverse research workforce in neuroscience. This initiative encourages applications from organizations proposing innovative mentoring and professional development activities to support individuals from underrepresented backgrounds in neuroscience research, focusing on enhancing retention and career advancement across various stages. The program is particularly significant for promoting diversity within the scientific workforce, which is essential for enhancing the quality and innovation potential of research. Interested applicants can apply for grants of up to $250,000 annually for a maximum of five years, with the application deadline set for September 26, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-178.html.
    PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) Grant Applications. This funding opportunity invites eligible U.S. small businesses to submit applications for Phase I, Phase II, Fast-Track, and Direct to Phase II projects that align with the research missions of the NIH, CDC, and FDA, with a focus on stimulating technological innovation and commercialization of federal R&D investments. Notably, applications must not include clinical trials, and funding levels are capped at $306,872 for Phase I and up to $2,045,816 for Phase II, with a submission deadline of April 5, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.